| GO:0006457 | protein folding | 25.88% (22/85) | 4.9 | 0.0 | 0.0 |
| GO:0061077 | chaperone-mediated protein folding | 20.0% (17/85) | 5.61 | 0.0 | 0.0 |
| GO:0009408 | response to heat | 32.94% (28/85) | 3.63 | 0.0 | 0.0 |
| GO:0031072 | heat shock protein binding | 18.82% (16/85) | 5.26 | 0.0 | 0.0 |
| GO:0035966 | response to topologically incorrect protein | 16.47% (14/85) | 5.65 | 0.0 | 0.0 |
| GO:0051082 | unfolded protein binding | 17.65% (15/85) | 5.12 | 0.0 | 0.0 |
| GO:0006986 | response to unfolded protein | 14.12% (12/85) | 5.79 | 0.0 | 0.0 |
| GO:0051087 | chaperone binding | 14.12% (12/85) | 5.37 | 0.0 | 0.0 |
| GO:0051085 | chaperone cofactor-dependent protein refolding | 12.94% (11/85) | 5.66 | 0.0 | 0.0 |
| GO:0051084 | 'de novo' post-translational protein folding | 12.94% (11/85) | 5.6 | 0.0 | 0.0 |
| GO:0006458 | 'de novo' protein folding | 12.94% (11/85) | 5.56 | 0.0 | 0.0 |
| GO:0034605 | cellular response to heat | 16.47% (14/85) | 4.48 | 0.0 | 0.0 |
| GO:0009266 | response to temperature stimulus | 35.29% (30/85) | 2.45 | 0.0 | 0.0 |
| GO:0035259 | nuclear glucocorticoid receptor binding | 7.06% (6/85) | 7.85 | 0.0 | 0.0 |
| GO:0030544 | Hsp70 protein binding | 10.59% (9/85) | 5.71 | 0.0 | 0.0 |
| GO:0042026 | protein refolding | 9.41% (8/85) | 5.82 | 0.0 | 0.0 |
| GO:0051131 | chaperone-mediated protein complex assembly | 7.06% (6/85) | 6.91 | 0.0 | 0.0 |
| GO:0043933 | protein-containing complex organization | 24.71% (21/85) | 2.63 | 0.0 | 0.0 |
| GO:1990634 | protein phosphatase 5 binding | 4.71% (4/85) | 8.52 | 0.0 | 0.0 |
| GO:0065003 | protein-containing complex assembly | 21.18% (18/85) | 2.6 | 0.0 | 0.0 |
| GO:0042981 | regulation of apoptotic process | 16.47% (14/85) | 3.13 | 0.0 | 0.0 |
| GO:0043067 | regulation of programmed cell death | 18.82% (16/85) | 2.74 | 0.0 | 0.0 |
| GO:0033554 | cellular response to stress | 32.94% (28/85) | 1.8 | 0.0 | 0.0 |
| GO:0032991 | protein-containing complex | 37.65% (32/85) | 1.61 | 0.0 | 0.0 |
| GO:0051219 | phosphoprotein binding | 7.06% (6/85) | 5.6 | 0.0 | 0.0 |
| GO:0101031 | chaperone complex | 7.06% (6/85) | 5.55 | 0.0 | 0.0 |
| GO:0042470 | melanosome | 7.06% (6/85) | 5.48 | 0.0 | 0.0 |
| GO:0048770 | pigment granule | 7.06% (6/85) | 5.34 | 0.0 | 1e-06 |
| GO:0044183 | protein folding chaperone | 7.06% (6/85) | 5.3 | 0.0 | 1e-06 |
| GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 4.71% (4/85) | 7.26 | 0.0 | 1e-06 |
| GO:0035967 | cellular response to topologically incorrect protein | 7.06% (6/85) | 5.26 | 0.0 | 1e-06 |
| GO:0031647 | regulation of protein stability | 11.76% (10/85) | 3.57 | 0.0 | 1e-06 |
| GO:0005829 | cytosol | 38.82% (33/85) | 1.45 | 0.0 | 1e-06 |
| GO:0010941 | regulation of cell death | 18.82% (16/85) | 2.48 | 0.0 | 1e-06 |
| GO:0071277 | cellular response to calcium ion | 5.88% (5/85) | 5.85 | 0.0 | 1e-06 |
| GO:0006886 | intracellular protein transport | 15.29% (13/85) | 2.86 | 0.0 | 1e-06 |
| GO:0030554 | adenyl nucleotide binding | 23.53% (20/85) | 2.09 | 0.0 | 1e-06 |
| GO:0046907 | intracellular transport | 18.82% (16/85) | 2.44 | 0.0 | 2e-06 |
| GO:0010922 | positive regulation of phosphatase activity | 4.71% (4/85) | 6.85 | 0.0 | 2e-06 |
| GO:0005524 | ATP binding | 22.35% (19/85) | 2.13 | 0.0 | 2e-06 |
| GO:0034620 | cellular response to unfolded protein | 5.88% (5/85) | 5.71 | 0.0 | 2e-06 |
| GO:0043066 | negative regulation of apoptotic process | 11.76% (10/85) | 3.35 | 0.0 | 2e-06 |
| GO:0040024 | dauer larval development | 4.71% (4/85) | 6.68 | 0.0 | 3e-06 |
| GO:0017076 | purine nucleotide binding | 24.71% (21/85) | 1.95 | 0.0 | 3e-06 |
| GO:0009628 | response to abiotic stimulus | 44.71% (38/85) | 1.22 | 0.0 | 3e-06 |
| GO:0035639 | purine ribonucleoside triphosphate binding | 23.53% (20/85) | 2.0 | 0.0 | 3e-06 |
| GO:0043168 | anion binding | 28.24% (24/85) | 1.74 | 0.0 | 3e-06 |
| GO:0010628 | positive regulation of gene expression | 15.29% (13/85) | 2.7 | 0.0 | 4e-06 |
| GO:0019904 | protein domain specific binding | 12.94% (11/85) | 3.03 | 0.0 | 4e-06 |
| GO:0006611 | protein export from nucleus | 4.71% (4/85) | 6.45 | 0.0 | 4e-06 |
| GO:0061629 | RNA polymerase II-specific DNA-binding transcription factor binding | 9.41% (8/85) | 3.78 | 0.0 | 5e-06 |
| GO:0032559 | adenyl ribonucleotide binding | 22.35% (19/85) | 2.02 | 0.0 | 5e-06 |
| GO:0016922 | nuclear receptor binding | 7.06% (6/85) | 4.66 | 0.0 | 5e-06 |
| GO:0005515 | protein binding | 65.88% (56/85) | 0.8 | 0.0 | 5e-06 |
| GO:0015031 | protein transport | 16.47% (14/85) | 2.5 | 0.0 | 5e-06 |
| GO:0051787 | misfolded protein binding | 5.88% (5/85) | 5.31 | 0.0 | 6e-06 |
| GO:0032728 | positive regulation of interferon-beta production | 4.71% (4/85) | 6.32 | 0.0 | 6e-06 |
| GO:0097367 | carbohydrate derivative binding | 24.71% (21/85) | 1.84 | 0.0 | 7e-06 |
| GO:0032555 | purine ribonucleotide binding | 23.53% (20/85) | 1.89 | 0.0 | 8e-06 |
| GO:0043069 | negative regulation of programmed cell death | 11.76% (10/85) | 3.1 | 0.0 | 8e-06 |
| GO:0051649 | establishment of localization in cell | 18.82% (16/85) | 2.22 | 0.0 | 8e-06 |
| GO:0022607 | cellular component assembly | 23.53% (20/85) | 1.89 | 0.0 | 8e-06 |
| GO:0032648 | regulation of interferon-beta production | 4.71% (4/85) | 6.09 | 0.0 | 1e-05 |
| GO:0060176 | regulation of aggregation involved in sorocarp development | 4.71% (4/85) | 6.09 | 0.0 | 1e-05 |
| GO:0045184 | establishment of protein localization | 16.47% (14/85) | 2.41 | 0.0 | 1e-05 |
| GO:0044743 | protein transmembrane import into intracellular organelle | 5.88% (5/85) | 5.1 | 0.0 | 1e-05 |
| GO:0008134 | transcription factor binding | 11.76% (10/85) | 3.04 | 0.0 | 1e-05 |
| GO:0032553 | ribonucleotide binding | 23.53% (20/85) | 1.85 | 0.0 | 1.1e-05 |
| GO:0071806 | protein transmembrane transport | 7.06% (6/85) | 4.36 | 1e-06 | 1.3e-05 |
| GO:0016043 | cellular component organization | 38.82% (33/85) | 1.25 | 1e-06 | 1.4e-05 |
| GO:0051716 | cellular response to stimulus | 36.47% (31/85) | 1.31 | 1e-06 | 1.5e-05 |
| GO:0098586 | cellular response to virus | 4.71% (4/85) | 5.89 | 1e-06 | 1.6e-05 |
| GO:0002164 | larval development | 5.88% (5/85) | 4.88 | 1e-06 | 2e-05 |
| GO:0036503 | ERAD pathway | 7.06% (6/85) | 4.23 | 1e-06 | 2.1e-05 |
| GO:0046677 | response to antibiotic | 5.88% (5/85) | 4.85 | 1e-06 | 2.2e-05 |
| GO:0048471 | perinuclear region of cytoplasm | 10.59% (9/85) | 3.12 | 1e-06 | 2.3e-05 |
| GO:0050821 | protein stabilization | 8.24% (7/85) | 3.74 | 1e-06 | 2.4e-05 |
| GO:0031686 | A1 adenosine receptor binding | 3.53% (3/85) | 7.11 | 1e-06 | 2.4e-05 |
| GO:0097213 | regulation of lysosomal membrane permeability | 3.53% (3/85) | 7.11 | 1e-06 | 2.4e-05 |
| GO:0097214 | positive regulation of lysosomal membrane permeability | 3.53% (3/85) | 7.11 | 1e-06 | 2.4e-05 |
| GO:1904593 | prostaglandin binding | 3.53% (3/85) | 7.11 | 1e-06 | 2.4e-05 |
| GO:1904764 | chaperone-mediated autophagy translocation complex disassembly | 3.53% (3/85) | 7.11 | 1e-06 | 2.4e-05 |
| GO:1990832 | slow axonal transport | 3.53% (3/85) | 7.11 | 1e-06 | 2.4e-05 |
| GO:1990833 | clathrin-uncoating ATPase activity | 3.53% (3/85) | 7.11 | 1e-06 | 2.4e-05 |
| GO:1990836 | lysosomal matrix | 3.53% (3/85) | 7.11 | 1e-06 | 2.4e-05 |
| GO:0033120 | positive regulation of RNA splicing | 5.88% (5/85) | 4.76 | 1e-06 | 2.5e-05 |
| GO:0001822 | kidney development | 5.88% (5/85) | 4.76 | 1e-06 | 2.5e-05 |
| GO:0070062 | extracellular exosome | 5.88% (5/85) | 4.74 | 1e-06 | 2.6e-05 |
| GO:0035307 | positive regulation of protein dephosphorylation | 4.71% (4/85) | 5.64 | 1e-06 | 2.6e-05 |
| GO:0048523 | negative regulation of cellular process | 30.59% (26/85) | 1.45 | 1e-06 | 2.6e-05 |
| GO:0043484 | regulation of RNA splicing | 8.24% (7/85) | 3.71 | 1e-06 | 2.7e-05 |
| GO:0065009 | regulation of molecular function | 20.0% (17/85) | 1.95 | 1e-06 | 2.9e-05 |
| GO:0060548 | negative regulation of cell death | 11.76% (10/85) | 2.83 | 1e-06 | 2.9e-05 |
| GO:0140297 | DNA-binding transcription factor binding | 9.41% (8/85) | 3.32 | 1e-06 | 2.9e-05 |
| GO:0008340 | determination of adult lifespan | 7.06% (6/85) | 4.09 | 2e-06 | 2.9e-05 |
| GO:0098690 | glycinergic synapse | 3.53% (3/85) | 6.97 | 2e-06 | 2.9e-05 |
| GO:0098880 | maintenance of postsynaptic specialization structure | 3.53% (3/85) | 6.97 | 2e-06 | 2.9e-05 |
| GO:0099558 | maintenance of synapse structure | 3.53% (3/85) | 6.97 | 2e-06 | 2.9e-05 |
| GO:0005102 | signaling receptor binding | 10.59% (9/85) | 3.04 | 2e-06 | 3e-05 |
| GO:0032481 | positive regulation of type I interferon production | 4.71% (4/85) | 5.49 | 2e-06 | 3.5e-05 |
| GO:0035306 | positive regulation of dephosphorylation | 4.71% (4/85) | 5.49 | 2e-06 | 3.5e-05 |
| GO:0048518 | positive regulation of biological process | 38.82% (33/85) | 1.17 | 2e-06 | 3.6e-05 |
| GO:0001916 | positive regulation of T cell mediated cytotoxicity | 3.53% (3/85) | 6.85 | 2e-06 | 3.6e-05 |
| GO:0031685 | adenosine receptor binding | 3.53% (3/85) | 6.85 | 2e-06 | 3.6e-05 |
| GO:0097106 | postsynaptic density organization | 3.53% (3/85) | 6.85 | 2e-06 | 3.6e-05 |
| GO:0099084 | postsynaptic specialization organization | 3.53% (3/85) | 6.85 | 2e-06 | 3.6e-05 |
| GO:0099634 | postsynaptic specialization membrane | 3.53% (3/85) | 6.85 | 2e-06 | 3.6e-05 |
| GO:0071840 | cellular component organization or biogenesis | 38.82% (33/85) | 1.16 | 2e-06 | 3.9e-05 |
| GO:0002684 | positive regulation of immune system process | 12.94% (11/85) | 2.56 | 3e-06 | 4.1e-05 |
| GO:0019222 | regulation of metabolic process | 41.18% (35/85) | 1.1 | 3e-06 | 4.2e-05 |
| GO:0001914 | regulation of T cell mediated cytotoxicity | 3.53% (3/85) | 6.73 | 3e-06 | 4.5e-05 |
| GO:0051603 | proteolysis involved in protein catabolic process | 12.94% (11/85) | 2.54 | 3e-06 | 4.7e-05 |
| GO:0009057 | macromolecule catabolic process | 16.47% (14/85) | 2.13 | 3e-06 | 5.1e-05 |
| GO:0048024 | regulation of mRNA splicing, via spliceosome | 7.06% (6/85) | 3.89 | 3e-06 | 5.4e-05 |
| GO:0002709 | regulation of T cell mediated immunity | 3.53% (3/85) | 6.62 | 4e-06 | 5.4e-05 |
| GO:0002711 | positive regulation of T cell mediated immunity | 3.53% (3/85) | 6.62 | 4e-06 | 5.4e-05 |
| GO:0061738 | late endosomal microautophagy | 3.53% (3/85) | 6.62 | 4e-06 | 5.4e-05 |
| GO:0010286 | heat acclimation | 8.24% (7/85) | 3.46 | 4e-06 | 5.6e-05 |
| GO:0030518 | intracellular steroid hormone receptor signaling pathway | 4.71% (4/85) | 5.26 | 4e-06 | 5.7e-05 |
| GO:0044265 | cellular macromolecule catabolic process | 14.12% (12/85) | 2.35 | 4e-06 | 6e-05 |
| GO:0002230 | positive regulation of defense response to virus by host | 4.71% (4/85) | 5.23 | 4e-06 | 6.1e-05 |
| GO:1903561 | extracellular vesicle | 5.88% (5/85) | 4.4 | 4e-06 | 6.2e-05 |
| GO:0045471 | response to ethanol | 5.88% (5/85) | 4.39 | 4e-06 | 6.3e-05 |
| GO:0043230 | extracellular organelle | 5.88% (5/85) | 4.39 | 4e-06 | 6.3e-05 |
| GO:0065010 | extracellular membrane-bounded organelle | 5.88% (5/85) | 4.39 | 4e-06 | 6.3e-05 |
| GO:0006511 | ubiquitin-dependent protein catabolic process | 11.76% (10/85) | 2.64 | 5e-06 | 6.6e-05 |
| GO:0032279 | asymmetric synapse | 2.35% (2/85) | 8.85 | 5e-06 | 6.7e-05 |
| GO:0016887 | ATP hydrolysis activity | 5.88% (5/85) | 4.36 | 5e-06 | 6.7e-05 |
| GO:0097718 | disordered domain specific binding | 4.71% (4/85) | 5.17 | 5e-06 | 6.7e-05 |
| GO:0019941 | modification-dependent protein catabolic process | 11.76% (10/85) | 2.63 | 5e-06 | 6.8e-05 |
| GO:0005488 | binding | 74.12% (63/85) | 0.57 | 5e-06 | 6.9e-05 |
| GO:0050691 | regulation of defense response to virus by host | 4.71% (4/85) | 5.14 | 5e-06 | 7.1e-05 |
| GO:0001912 | positive regulation of leukocyte mediated cytotoxicity | 3.53% (3/85) | 6.43 | 5e-06 | 7.3e-05 |
| GO:0031343 | positive regulation of cell killing | 3.53% (3/85) | 6.43 | 5e-06 | 7.3e-05 |
| GO:0032479 | regulation of type I interferon production | 4.71% (4/85) | 5.09 | 6e-06 | 8.1e-05 |
| GO:0072594 | establishment of protein localization to organelle | 9.41% (8/85) | 3.03 | 6e-06 | 8.5e-05 |
| GO:0016191 | synaptic vesicle uncoating | 3.53% (3/85) | 6.34 | 7e-06 | 8.6e-05 |
| GO:0043632 | modification-dependent macromolecule catabolic process | 11.76% (10/85) | 2.58 | 7e-06 | 8.7e-05 |
| GO:0030433 | ubiquitin-dependent ERAD pathway | 5.88% (5/85) | 4.21 | 8e-06 | 0.000102 |
| GO:0043198 | dendritic shaft | 3.53% (3/85) | 6.26 | 8e-06 | 0.000102 |
| GO:0001910 | regulation of leukocyte mediated cytotoxicity | 3.53% (3/85) | 6.18 | 9e-06 | 0.000117 |
| GO:0044829 | positive regulation by host of viral genome replication | 3.53% (3/85) | 6.18 | 9e-06 | 0.000117 |
| GO:0072318 | clathrin coat disassembly | 3.53% (3/85) | 6.18 | 9e-06 | 0.000117 |
| GO:0002119 | nematode larval development | 4.71% (4/85) | 4.94 | 9e-06 | 0.000118 |
| GO:0030163 | protein catabolic process | 10.59% (9/85) | 2.71 | 1e-05 | 0.000122 |
| GO:0051592 | response to calcium ion | 5.88% (5/85) | 4.14 | 1e-05 | 0.000123 |
| GO:0043666 | regulation of phosphoprotein phosphatase activity | 4.71% (4/85) | 4.89 | 1.1e-05 | 0.000129 |
| GO:0032570 | response to progesterone | 3.53% (3/85) | 6.11 | 1.1e-05 | 0.000134 |
| GO:0044093 | positive regulation of molecular function | 11.76% (10/85) | 2.48 | 1.2e-05 | 0.000146 |
| GO:0048026 | positive regulation of mRNA splicing, via spliceosome | 4.71% (4/85) | 4.82 | 1.3e-05 | 0.000151 |
| GO:0030521 | androgen receptor signaling pathway | 3.53% (3/85) | 6.04 | 1.3e-05 | 0.000152 |
| GO:0009893 | positive regulation of metabolic process | 25.88% (22/85) | 1.42 | 1.3e-05 | 0.000152 |
| GO:0050684 | regulation of mRNA processing | 7.06% (6/85) | 3.56 | 1.3e-05 | 0.000152 |
| GO:0043085 | positive regulation of catalytic activity | 9.41% (8/85) | 2.88 | 1.4e-05 | 0.000162 |
| GO:0008104 | protein localization | 16.47% (14/85) | 1.95 | 1.4e-05 | 0.000162 |
| GO:0006913 | nucleocytoplasmic transport | 7.06% (6/85) | 3.52 | 1.5e-05 | 0.000173 |
| GO:0010921 | regulation of phosphatase activity | 4.71% (4/85) | 4.76 | 1.5e-05 | 0.000174 |
| GO:0051169 | nuclear transport | 7.06% (6/85) | 3.51 | 1.6e-05 | 0.000179 |
| GO:0031323 | regulation of cellular metabolic process | 35.29% (30/85) | 1.11 | 1.6e-05 | 0.000184 |
| GO:0044248 | cellular catabolic process | 21.18% (18/85) | 1.62 | 1.6e-05 | 0.000185 |
| GO:0034331 | cell junction maintenance | 3.53% (3/85) | 5.91 | 1.7e-05 | 0.000189 |
| GO:0097212 | lysosomal membrane organization | 3.53% (3/85) | 5.91 | 1.7e-05 | 0.000189 |
| GO:0010604 | positive regulation of macromolecule metabolic process | 23.53% (20/85) | 1.49 | 1.8e-05 | 0.000202 |
| GO:0010033 | response to organic substance | 37.65% (32/85) | 1.05 | 1.8e-05 | 0.000202 |
| GO:0043954 | cellular component maintenance | 3.53% (3/85) | 5.85 | 1.9e-05 | 0.000211 |
| GO:0050685 | positive regulation of mRNA processing | 4.71% (4/85) | 4.66 | 2e-05 | 0.000219 |
| GO:0034976 | response to endoplasmic reticulum stress | 7.06% (6/85) | 3.42 | 2.2e-05 | 0.00023 |
| GO:0010045 | response to nickel cation | 3.53% (3/85) | 5.79 | 2.2e-05 | 0.000231 |
| GO:0044794 | positive regulation by host of viral process | 3.53% (3/85) | 5.79 | 2.2e-05 | 0.000231 |
| GO:0072319 | vesicle uncoating | 3.53% (3/85) | 5.79 | 2.2e-05 | 0.000231 |
| GO:1901567 | fatty acid derivative binding | 3.53% (3/85) | 5.79 | 2.2e-05 | 0.000231 |
| GO:1905710 | positive regulation of membrane permeability | 3.53% (3/85) | 5.79 | 2.2e-05 | 0.000231 |
| GO:0006950 | response to stress | 49.41% (42/85) | 0.82 | 2.3e-05 | 0.000239 |
| GO:0009056 | catabolic process | 23.53% (20/85) | 1.47 | 2.3e-05 | 0.00024 |
| GO:0001664 | G protein-coupled receptor binding | 4.71% (4/85) | 4.56 | 2.6e-05 | 0.000269 |
| GO:1902007 | regulation of toxin transport | 2.35% (2/85) | 7.85 | 2.8e-05 | 0.000284 |
| GO:1902009 | positive regulation of toxin transport | 2.35% (2/85) | 7.85 | 2.8e-05 | 0.000284 |
| GO:0046686 | response to cadmium ion | 11.76% (10/85) | 2.34 | 2.8e-05 | 0.000285 |
| GO:0000166 | nucleotide binding | 25.88% (22/85) | 1.35 | 2.9e-05 | 0.000289 |
| GO:1901265 | nucleoside phosphate binding | 25.88% (22/85) | 1.35 | 2.9e-05 | 0.000289 |
| GO:0043462 | regulation of ATP-dependent activity | 4.71% (4/85) | 4.52 | 2.9e-05 | 0.000291 |
| GO:0001786 | phosphatidylserine binding | 3.53% (3/85) | 5.62 | 3.1e-05 | 0.000308 |
| GO:0071248 | cellular response to metal ion | 5.88% (5/85) | 3.8 | 3.1e-05 | 0.000309 |
| GO:0019538 | protein metabolic process | 30.59% (26/85) | 1.18 | 3.3e-05 | 0.000319 |
| GO:0051641 | cellular localization | 18.82% (16/85) | 1.67 | 3.4e-05 | 0.000326 |
| GO:0099523 | presynaptic cytosol | 3.53% (3/85) | 5.57 | 3.5e-05 | 0.000336 |
| GO:0005730 | nucleolus | 14.12% (12/85) | 2.02 | 3.8e-05 | 0.000363 |
| GO:0044827 | modulation by host of viral genome replication | 3.53% (3/85) | 5.52 | 3.9e-05 | 0.000369 |
| GO:0043228 | non-membrane-bounded organelle | 23.53% (20/85) | 1.41 | 4e-05 | 0.000374 |
| GO:0043232 | intracellular non-membrane-bounded organelle | 23.53% (20/85) | 1.41 | 4e-05 | 0.000374 |
| GO:0010468 | regulation of gene expression | 29.41% (25/85) | 1.2 | 4.2e-05 | 0.000389 |
| GO:0048519 | negative regulation of biological process | 32.94% (28/85) | 1.1 | 4.1e-05 | 0.000389 |
| GO:0032780 | negative regulation of ATP-dependent activity | 3.53% (3/85) | 5.48 | 4.3e-05 | 0.000397 |
| GO:0036094 | small molecule binding | 27.06% (23/85) | 1.27 | 4.3e-05 | 0.000401 |
| GO:0072655 | establishment of protein localization to mitochondrion | 4.71% (4/85) | 4.37 | 4.4e-05 | 0.000407 |
| GO:0070727 | cellular macromolecule localization | 16.47% (14/85) | 1.79 | 4.5e-05 | 0.000413 |
| GO:0051171 | regulation of nitrogen compound metabolic process | 31.76% (27/85) | 1.13 | 4.5e-05 | 0.000413 |
| GO:0099128 | mitochondrial iron-sulfur cluster assembly complex | 2.35% (2/85) | 7.52 | 4.7e-05 | 0.000422 |
| GO:0090559 | regulation of membrane permeability | 3.53% (3/85) | 5.43 | 4.7e-05 | 0.000424 |
| GO:0002020 | protease binding | 4.71% (4/85) | 4.34 | 4.8e-05 | 0.000432 |
| GO:0043167 | ion binding | 36.47% (31/85) | 1.01 | 4.9e-05 | 0.000434 |
| GO:0070585 | protein localization to mitochondrion | 4.71% (4/85) | 4.32 | 5e-05 | 0.000447 |
| GO:0048522 | positive regulation of cellular process | 30.59% (26/85) | 1.14 | 5.3e-05 | 0.000469 |
| GO:0019899 | enzyme binding | 17.65% (15/85) | 1.69 | 5.5e-05 | 0.000482 |
| GO:0031341 | regulation of cell killing | 3.53% (3/85) | 5.34 | 5.7e-05 | 0.000495 |
| GO:0050896 | response to stimulus | 60.0% (51/85) | 0.63 | 5.8e-05 | 0.000505 |
| GO:0050688 | regulation of defense response to virus | 4.71% (4/85) | 4.26 | 5.9e-05 | 0.000515 |
| GO:0050920 | regulation of chemotaxis | 4.71% (4/85) | 4.25 | 6.2e-05 | 0.000534 |
| GO:0002682 | regulation of immune system process | 15.29% (13/85) | 1.84 | 6.4e-05 | 0.000547 |
| GO:0005681 | spliceosomal complex | 7.06% (6/85) | 3.14 | 6.5e-05 | 0.000552 |
| GO:0051129 | negative regulation of cellular component organization | 8.24% (7/85) | 2.81 | 6.6e-05 | 0.000561 |
| GO:0050794 | regulation of cellular process | 49.41% (42/85) | 0.76 | 6.7e-05 | 0.000568 |
| GO:0065007 | biological regulation | 57.65% (49/85) | 0.65 | 6.8e-05 | 0.000569 |
| GO:0044788 | modulation by host of viral process | 3.53% (3/85) | 5.26 | 6.7e-05 | 0.00057 |
| GO:0006463 | steroid hormone receptor complex assembly | 2.35% (2/85) | 7.26 | 7e-05 | 0.000577 |
| GO:0030850 | prostate gland development | 2.35% (2/85) | 7.26 | 7e-05 | 0.000577 |
| GO:0035101 | FACT complex | 2.35% (2/85) | 7.26 | 7e-05 | 0.000577 |
| GO:0071705 | nitrogen compound transport | 16.47% (14/85) | 1.73 | 7.1e-05 | 0.000581 |
| GO:0006260 | DNA replication | 5.88% (5/85) | 3.55 | 7.1e-05 | 0.000582 |
| GO:0060255 | regulation of macromolecule metabolic process | 32.94% (28/85) | 1.06 | 7.1e-05 | 0.000583 |
| GO:1902904 | negative regulation of supramolecular fiber organization | 4.71% (4/85) | 4.19 | 7.2e-05 | 0.000588 |
| GO:0009987 | cellular process | 72.94% (62/85) | 0.48 | 7.4e-05 | 0.000602 |
| GO:0000974 | Prp19 complex | 3.53% (3/85) | 5.14 | 8.6e-05 | 0.00069 |
| GO:0006839 | mitochondrial transport | 4.71% (4/85) | 4.1 | 9.1e-05 | 0.000726 |
| GO:0002821 | positive regulation of adaptive immune response | 3.53% (3/85) | 5.11 | 9.3e-05 | 0.000735 |
| GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 3.53% (3/85) | 5.11 | 9.3e-05 | 0.000735 |
| GO:0035304 | regulation of protein dephosphorylation | 4.71% (4/85) | 4.09 | 9.4e-05 | 0.00074 |
| GO:0022618 | ribonucleoprotein complex assembly | 7.06% (6/85) | 3.04 | 9.4e-05 | 0.000742 |
| GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane | 2.35% (2/85) | 7.04 | 9.7e-05 | 0.000761 |
| GO:0070678 | preprotein binding | 2.35% (2/85) | 7.04 | 9.7e-05 | 0.000761 |
| GO:0002708 | positive regulation of lymphocyte mediated immunity | 3.53% (3/85) | 5.07 | 0.0001 | 0.000774 |
| GO:0006810 | transport | 25.88% (22/85) | 1.22 | 0.000111 | 0.000857 |
| GO:0050790 | regulation of catalytic activity | 12.94% (11/85) | 1.97 | 0.000113 | 0.00087 |
| GO:0044309 | neuron spine | 3.53% (3/85) | 5.0 | 0.000115 | 0.000878 |
| GO:0099522 | cytosolic region | 3.53% (3/85) | 5.0 | 0.000115 | 0.000878 |
| GO:0002699 | positive regulation of immune effector process | 4.71% (4/85) | 4.01 | 0.000116 | 0.000881 |
| GO:0005654 | nucleoplasm | 15.29% (13/85) | 1.74 | 0.000123 | 0.000926 |
| GO:0031090 | organelle membrane | 28.24% (24/85) | 1.14 | 0.000124 | 0.000928 |
| GO:0002706 | regulation of lymphocyte mediated immunity | 3.53% (3/85) | 4.97 | 0.000123 | 0.000929 |
| GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 3.53% (3/85) | 4.97 | 0.000123 | 0.000929 |
| GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 8.24% (7/85) | 2.66 | 0.000127 | 0.000945 |
| GO:0019903 | protein phosphatase binding | 4.71% (4/85) | 3.97 | 0.000128 | 0.000946 |
| GO:0035303 | regulation of dephosphorylation | 4.71% (4/85) | 3.97 | 0.000128 | 0.000946 |
| GO:0071826 | ribonucleoprotein complex subunit organization | 7.06% (6/85) | 2.96 | 0.000129 | 0.000947 |
| GO:0009107 | lipoate biosynthetic process | 2.35% (2/85) | 6.85 | 0.00013 | 0.000947 |
| GO:0046661 | male sex differentiation | 2.35% (2/85) | 6.85 | 0.00013 | 0.000947 |
| GO:0001819 | positive regulation of cytokine production | 4.71% (4/85) | 3.96 | 0.000132 | 0.000954 |
| GO:0000245 | spliceosomal complex assembly | 3.53% (3/85) | 4.94 | 0.000132 | 0.000954 |
| GO:0002819 | regulation of adaptive immune response | 3.53% (3/85) | 4.94 | 0.000132 | 0.000954 |
| GO:0009615 | response to virus | 8.24% (7/85) | 2.65 | 0.000133 | 0.000955 |
| GO:0080090 | regulation of primary metabolic process | 31.76% (27/85) | 1.03 | 0.000139 | 0.000997 |
| GO:0033036 | macromolecule localization | 16.47% (14/85) | 1.64 | 0.000144 | 0.001028 |
| GO:0006914 | autophagy | 5.88% (5/85) | 3.33 | 0.000145 | 0.001029 |
| GO:0009570 | chloroplast stroma | 10.59% (9/85) | 2.21 | 0.000147 | 0.001039 |
| GO:0043195 | terminal bouton | 3.53% (3/85) | 4.88 | 0.00015 | 0.001057 |
| GO:1901575 | organic substance catabolic process | 20.0% (17/85) | 1.43 | 0.000152 | 0.001068 |
| GO:1990904 | ribonucleoprotein complex | 11.76% (10/85) | 2.04 | 0.000156 | 0.00108 |
| GO:0032104 | regulation of response to extracellular stimulus | 4.71% (4/85) | 3.9 | 0.000155 | 0.00108 |
| GO:0032107 | regulation of response to nutrient levels | 4.71% (4/85) | 3.9 | 0.000155 | 0.00108 |
| GO:0061919 | process utilizing autophagic mechanism | 5.88% (5/85) | 3.31 | 0.000157 | 0.001086 |
| GO:0051261 | protein depolymerization | 3.53% (3/85) | 4.85 | 0.00016 | 0.0011 |
| GO:0071310 | cellular response to organic substance | 14.12% (12/85) | 1.8 | 0.000163 | 0.001118 |
| GO:0061740 | protein targeting to lysosome involved in chaperone-mediated autophagy | 2.35% (2/85) | 6.68 | 0.000167 | 0.001133 |
| GO:0120293 | dynein axonemal particle | 2.35% (2/85) | 6.68 | 0.000167 | 0.001133 |
| GO:0002697 | regulation of immune effector process | 4.71% (4/85) | 3.87 | 0.00017 | 0.001149 |
| GO:0099175 | regulation of postsynapse organization | 3.53% (3/85) | 4.82 | 0.00017 | 0.001152 |
| GO:0070887 | cellular response to chemical stimulus | 20.0% (17/85) | 1.41 | 0.000172 | 0.001158 |
| GO:0098798 | mitochondrial protein-containing complex | 5.88% (5/85) | 3.25 | 0.000191 | 0.001276 |
| GO:0040012 | regulation of locomotion | 7.06% (6/85) | 2.85 | 0.000191 | 0.001281 |
| GO:0009532 | plastid stroma | 10.59% (9/85) | 2.15 | 0.000194 | 0.001285 |
| GO:0043170 | macromolecule metabolic process | 40.0% (34/85) | 0.84 | 0.000194 | 0.001288 |
| GO:0001671 | ATPase activator activity | 3.53% (3/85) | 4.73 | 0.000203 | 0.00134 |
| GO:0010498 | proteasomal protein catabolic process | 8.24% (7/85) | 2.54 | 0.000208 | 0.001343 |
| GO:1990718 | axonemal central pair projection | 2.35% (2/85) | 6.52 | 0.000208 | 0.001347 |
| GO:0000035 | acyl binding | 2.35% (2/85) | 6.52 | 0.000208 | 0.001347 |
| GO:0009106 | lipoate metabolic process | 2.35% (2/85) | 6.52 | 0.000208 | 0.001347 |
| GO:0042221 | response to chemical | 42.35% (36/85) | 0.8 | 0.000206 | 0.001351 |
| GO:0006508 | proteolysis | 12.94% (11/85) | 1.87 | 0.000207 | 0.001353 |
| GO:0051234 | establishment of localization | 25.88% (22/85) | 1.16 | 0.000211 | 0.001355 |
| GO:0010038 | response to metal ion | 14.12% (12/85) | 1.75 | 0.000223 | 0.001431 |
| GO:0036477 | somatodendritic compartment | 3.53% (3/85) | 4.68 | 0.000227 | 0.001451 |
| GO:0080135 | regulation of cellular response to stress | 9.41% (8/85) | 2.29 | 0.000232 | 0.001473 |
| GO:0017111 | ribonucleoside triphosphate phosphatase activity | 7.06% (6/85) | 2.8 | 0.000232 | 0.001477 |
| GO:0002705 | positive regulation of leukocyte mediated immunity | 3.53% (3/85) | 4.65 | 0.00024 | 0.001516 |
| GO:1903895 | negative regulation of IRE1-mediated unfolded protein response | 2.35% (2/85) | 6.39 | 0.000254 | 0.001576 |
| GO:0055131 | C3HC4-type RING finger domain binding | 2.35% (2/85) | 6.39 | 0.000254 | 0.001576 |
| GO:0042030 | ATPase inhibitor activity | 2.35% (2/85) | 6.39 | 0.000254 | 0.001576 |
| GO:0045766 | positive regulation of angiogenesis | 2.35% (2/85) | 6.39 | 0.000254 | 0.001576 |
| GO:1904018 | positive regulation of vasculature development | 2.35% (2/85) | 6.39 | 0.000254 | 0.001576 |
| GO:0030522 | intracellular receptor signaling pathway | 4.71% (4/85) | 3.72 | 0.000255 | 0.001578 |
| GO:0051173 | positive regulation of nitrogen compound metabolic process | 20.0% (17/85) | 1.36 | 0.000258 | 0.001593 |
| GO:0003729 | mRNA binding | 14.12% (12/85) | 1.72 | 0.00026 | 0.001601 |
| GO:1903311 | regulation of mRNA metabolic process | 7.06% (6/85) | 2.75 | 0.000276 | 0.001689 |
| GO:1901363 | heterocyclic compound binding | 42.35% (36/85) | 0.78 | 0.000277 | 0.001693 |
| GO:0043204 | perikaryon | 3.53% (3/85) | 4.57 | 0.000281 | 0.001709 |
| GO:1904158 | axonemal central apparatus assembly | 2.35% (2/85) | 6.26 | 0.000304 | 0.001838 |
| GO:0071211 | protein targeting to vacuole involved in autophagy | 2.35% (2/85) | 6.26 | 0.000304 | 0.001838 |
| GO:0001666 | response to hypoxia | 8.24% (7/85) | 2.45 | 0.000308 | 0.001853 |
| GO:0005794 | Golgi apparatus | 12.94% (11/85) | 1.8 | 0.000309 | 0.001856 |
| GO:0033365 | protein localization to organelle | 9.41% (8/85) | 2.23 | 0.000315 | 0.001885 |
| GO:0097159 | organic cyclic compound binding | 42.35% (36/85) | 0.77 | 0.00032 | 0.001909 |
| GO:0051168 | nuclear export | 4.71% (4/85) | 3.63 | 0.000323 | 0.00192 |
| GO:0019902 | phosphatase binding | 4.71% (4/85) | 3.6 | 0.000348 | 0.002064 |
| GO:0097224 | sperm connecting piece | 2.35% (2/85) | 6.14 | 0.000359 | 0.002112 |
| GO:0007566 | embryo implantation | 2.35% (2/85) | 6.14 | 0.000359 | 0.002112 |
| GO:0005575 | cellular_component | 78.82% (67/85) | 0.37 | 0.000363 | 0.00213 |
| GO:0031625 | ubiquitin protein ligase binding | 7.06% (6/85) | 2.67 | 0.000383 | 0.002237 |
| GO:0098800 | inner mitochondrial membrane protein complex | 4.71% (4/85) | 3.55 | 0.000394 | 0.002288 |
| GO:0002703 | regulation of leukocyte mediated immunity | 3.53% (3/85) | 4.41 | 0.000393 | 0.002292 |
| GO:0050789 | regulation of biological process | 51.76% (44/85) | 0.63 | 0.000402 | 0.002329 |
| GO:0000036 | acyl carrier activity | 2.35% (2/85) | 6.04 | 0.000418 | 0.002383 |
| GO:0044571 | [2Fe-2S] cluster assembly | 2.35% (2/85) | 6.04 | 0.000418 | 0.002383 |
| GO:0044620 | ACP phosphopantetheine attachment site binding | 2.35% (2/85) | 6.04 | 0.000418 | 0.002383 |
| GO:0051192 | prosthetic group binding | 2.35% (2/85) | 6.04 | 0.000418 | 0.002383 |
| GO:0140414 | phosphopantetheine-dependent carrier activity | 2.35% (2/85) | 6.04 | 0.000418 | 0.002383 |
| GO:0044877 | protein-containing complex binding | 10.59% (9/85) | 2.0 | 0.000427 | 0.002424 |
| GO:0008088 | axo-dendritic transport | 3.53% (3/85) | 4.36 | 0.00043 | 0.002435 |
| GO:0036293 | response to decreased oxygen levels | 8.24% (7/85) | 2.36 | 0.000443 | 0.002498 |
| GO:0140104 | molecular carrier activity | 3.53% (3/85) | 4.34 | 0.000449 | 0.002527 |
| GO:0140677 | molecular function activator activity | 3.53% (3/85) | 4.32 | 0.000469 | 0.002629 |
| GO:1903894 | regulation of IRE1-mediated unfolded protein response | 2.35% (2/85) | 5.94 | 0.000482 | 0.002653 |
| GO:0042689 | regulation of crystal cell differentiation | 2.35% (2/85) | 5.94 | 0.000482 | 0.002653 |
| GO:0042691 | positive regulation of crystal cell differentiation | 2.35% (2/85) | 5.94 | 0.000482 | 0.002653 |
| GO:0045612 | positive regulation of hemocyte differentiation | 2.35% (2/85) | 5.94 | 0.000482 | 0.002653 |
| GO:0009249 | protein lipoylation | 2.35% (2/85) | 5.94 | 0.000482 | 0.002653 |
| GO:0000492 | box C/D snoRNP assembly | 2.35% (2/85) | 5.94 | 0.000482 | 0.002653 |
| GO:0071702 | organic substance transport | 16.47% (14/85) | 1.46 | 0.000486 | 0.00266 |
| GO:0044389 | ubiquitin-like protein ligase binding | 7.06% (6/85) | 2.6 | 0.000485 | 0.002661 |
| GO:0110165 | cellular anatomical entity | 77.65% (66/85) | 0.37 | 0.000496 | 0.002708 |
| GO:0051247 | positive regulation of protein metabolic process | 10.59% (9/85) | 1.97 | 0.0005 | 0.002717 |
| GO:0008150 | biological_process | 78.82% (67/85) | 0.36 | 0.000506 | 0.002746 |
| GO:0051851 | modulation by host of symbiont process | 3.53% (3/85) | 4.28 | 0.00051 | 0.002756 |
| GO:0031325 | positive regulation of cellular metabolic process | 20.0% (17/85) | 1.27 | 0.000533 | 0.002872 |
| GO:0051240 | positive regulation of multicellular organismal process | 10.59% (9/85) | 1.95 | 0.000542 | 0.00291 |
| GO:0050750 | low-density lipoprotein particle receptor binding | 2.35% (2/85) | 5.85 | 0.00055 | 0.002911 |
| GO:0070325 | lipoprotein particle receptor binding | 2.35% (2/85) | 5.85 | 0.00055 | 0.002911 |
| GO:0031386 | protein tag | 2.35% (2/85) | 5.85 | 0.00055 | 0.002911 |
| GO:0035096 | larval midgut cell programmed cell death | 2.35% (2/85) | 5.85 | 0.00055 | 0.002911 |
| GO:1990204 | oxidoreductase complex | 4.71% (4/85) | 3.43 | 0.000543 | 0.002911 |
| GO:0033108 | mitochondrial respiratory chain complex assembly | 3.53% (3/85) | 4.24 | 0.000553 | 0.002919 |
| GO:0050808 | synapse organization | 3.53% (3/85) | 4.22 | 0.000575 | 0.003029 |
| GO:0005618 | cell wall | 14.12% (12/85) | 1.59 | 0.000591 | 0.003105 |
| GO:0051179 | localization | 27.06% (23/85) | 1.02 | 0.000598 | 0.003128 |
| GO:0070482 | response to oxygen levels | 8.24% (7/85) | 2.28 | 0.00061 | 0.003184 |
| GO:1902289 | negative regulation of defense response to oomycetes | 2.35% (2/85) | 5.76 | 0.000622 | 0.003219 |
| GO:0098984 | neuron to neuron synapse | 2.35% (2/85) | 5.76 | 0.000622 | 0.003219 |
| GO:0000491 | small nucleolar ribonucleoprotein complex assembly | 2.35% (2/85) | 5.76 | 0.000622 | 0.003219 |
| GO:0098760 | response to interleukin-7 | 2.35% (2/85) | 5.68 | 0.000699 | 0.003595 |
| GO:0098761 | cellular response to interleukin-7 | 2.35% (2/85) | 5.68 | 0.000699 | 0.003595 |
| GO:0001817 | regulation of cytokine production | 4.71% (4/85) | 3.31 | 0.000729 | 0.00374 |
| GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response | 2.35% (2/85) | 5.6 | 0.00078 | 0.003978 |
| GO:0005705 | polytene chromosome interband | 2.35% (2/85) | 5.6 | 0.00078 | 0.003978 |
| GO:0051345 | positive regulation of hydrolase activity | 4.71% (4/85) | 3.27 | 0.000821 | 0.004177 |
| GO:0016462 | pyrophosphatase activity | 7.06% (6/85) | 2.45 | 0.000826 | 0.004187 |
| GO:0097060 | synaptic membrane | 3.53% (3/85) | 4.04 | 0.000833 | 0.00421 |
| GO:0010665 | regulation of cardiac muscle cell apoptotic process | 2.35% (2/85) | 5.52 | 0.000866 | 0.004352 |
| GO:0010667 | negative regulation of cardiac muscle cell apoptotic process | 2.35% (2/85) | 5.52 | 0.000866 | 0.004352 |
| GO:0003674 | molecular_function | 76.47% (65/85) | 0.36 | 0.000879 | 0.004406 |
| GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 7.06% (6/85) | 2.43 | 0.000887 | 0.004433 |
| GO:0071241 | cellular response to inorganic substance | 5.88% (5/85) | 2.76 | 0.000898 | 0.004477 |
| GO:0030575 | nuclear body organization | 2.35% (2/85) | 5.45 | 0.000955 | 0.00475 |
| GO:0030312 | external encapsulating structure | 14.12% (12/85) | 1.51 | 0.000971 | 0.004815 |
| GO:1902903 | regulation of supramolecular fiber organization | 4.71% (4/85) | 3.19 | 0.001011 | 0.004999 |
| GO:0098684 | photoreceptor ribbon synapse | 2.35% (2/85) | 5.39 | 0.001049 | 0.005147 |
| GO:0005762 | mitochondrial large ribosomal subunit | 2.35% (2/85) | 5.39 | 0.001049 | 0.005147 |
| GO:0006120 | mitochondrial electron transport, NADH to ubiquinone | 2.35% (2/85) | 5.39 | 0.001049 | 0.005147 |
| GO:0016817 | hydrolase activity, acting on acid anhydrides | 7.06% (6/85) | 2.38 | 0.001069 | 0.00523 |
| GO:0003723 | RNA binding | 16.47% (14/85) | 1.34 | 0.001115 | 0.005439 |
| GO:0045610 | regulation of hemocyte differentiation | 2.35% (2/85) | 5.32 | 0.001148 | 0.005568 |
| GO:2000378 | negative regulation of reactive oxygen species metabolic process | 2.35% (2/85) | 5.32 | 0.001148 | 0.005568 |
| GO:0043005 | neuron projection | 7.06% (6/85) | 2.35 | 0.001177 | 0.005692 |
| GO:0048046 | apoplast | 9.41% (8/85) | 1.93 | 0.001224 | 0.005904 |
| GO:0043401 | steroid hormone mediated signaling pathway | 4.71% (4/85) | 3.1 | 0.001251 | 0.005955 |
| GO:0010662 | regulation of striated muscle cell apoptotic process | 2.35% (2/85) | 5.26 | 0.00125 | 0.005969 |
| GO:0010664 | negative regulation of striated muscle cell apoptotic process | 2.35% (2/85) | 5.26 | 0.00125 | 0.005969 |
| GO:0006622 | protein targeting to lysosome | 2.35% (2/85) | 5.26 | 0.00125 | 0.005969 |
| GO:0030864 | cortical actin cytoskeleton | 2.35% (2/85) | 5.26 | 0.00125 | 0.005969 |
| GO:0050778 | positive regulation of immune response | 8.24% (7/85) | 2.1 | 0.001259 | 0.005981 |
| GO:1903313 | positive regulation of mRNA metabolic process | 4.71% (4/85) | 3.1 | 0.001272 | 0.006026 |
| GO:0009934 | regulation of meristem structural organization | 3.53% (3/85) | 3.82 | 0.0013 | 0.006143 |
| GO:0005739 | mitochondrion | 14.12% (12/85) | 1.46 | 0.00131 | 0.006173 |
| GO:0099524 | postsynaptic cytosol | 2.35% (2/85) | 5.2 | 0.001357 | 0.006344 |
| GO:0031111 | negative regulation of microtubule polymerization or depolymerization | 2.35% (2/85) | 5.2 | 0.001357 | 0.006344 |
| GO:0010035 | response to inorganic substance | 21.18% (18/85) | 1.11 | 0.001355 | 0.006369 |
| GO:0016363 | nuclear matrix | 3.53% (3/85) | 3.79 | 0.001378 | 0.006426 |
| GO:1901565 | organonitrogen compound catabolic process | 10.59% (9/85) | 1.75 | 0.001397 | 0.006496 |
| GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 3.53% (3/85) | 3.77 | 0.001418 | 0.006578 |
| GO:0140513 | nuclear protein-containing complex | 11.76% (10/85) | 1.63 | 0.001446 | 0.006687 |
| GO:0061083 | regulation of protein refolding | 2.35% (2/85) | 5.14 | 0.001468 | 0.006757 |
| GO:0097470 | ribbon synapse | 2.35% (2/85) | 5.14 | 0.001468 | 0.006757 |
| GO:0010656 | negative regulation of muscle cell apoptotic process | 2.35% (2/85) | 5.09 | 0.001583 | 0.007269 |
| GO:0018193 | peptidyl-amino acid modification | 9.41% (8/85) | 1.86 | 0.00167 | 0.007649 |
| GO:0000315 | organellar large ribosomal subunit | 2.35% (2/85) | 5.04 | 0.001703 | 0.007738 |
| GO:0007548 | sex differentiation | 2.35% (2/85) | 5.04 | 0.001703 | 0.007738 |
| GO:0048156 | tau protein binding | 2.35% (2/85) | 5.04 | 0.001703 | 0.007738 |
| GO:0044391 | ribosomal subunit | 5.88% (5/85) | 2.54 | 0.001739 | 0.007882 |
| GO:0016020 | membrane | 43.53% (37/85) | 0.63 | 0.001759 | 0.007953 |
| GO:0007049 | cell cycle | 7.06% (6/85) | 2.23 | 0.00181 | 0.008164 |
| GO:0006139 | nucleobase-containing compound metabolic process | 21.18% (18/85) | 1.07 | 0.001836 | 0.008259 |
| GO:0065002 | intracellular protein transmembrane transport | 3.53% (3/85) | 3.61 | 0.001956 | 0.008776 |
| GO:0007018 | microtubule-based movement | 4.71% (4/85) | 2.92 | 0.001989 | 0.008905 |
| GO:0042802 | identical protein binding | 17.65% (15/85) | 1.2 | 0.001994 | 0.008905 |
| GO:0005765 | lysosomal membrane | 3.53% (3/85) | 3.6 | 0.002005 | 0.00891 |
| GO:0036211 | protein modification process | 21.18% (18/85) | 1.06 | 0.002003 | 0.008921 |
| GO:0001834 | trophectodermal cell proliferation | 1.18% (1/85) | 8.85 | 0.002175 | 0.00952 |
| GO:0097504 | Gemini of coiled bodies | 1.18% (1/85) | 8.85 | 0.002175 | 0.00952 |
| GO:1990261 | pre-mRNA catabolic process | 1.18% (1/85) | 8.85 | 0.002175 | 0.00952 |
| GO:0060008 | Sertoli cell differentiation | 1.18% (1/85) | 8.85 | 0.002175 | 0.00952 |
| GO:0010619 | adenylate cyclase-activating glucose-activated G protein-coupled receptor signaling pathway | 1.18% (1/85) | 8.85 | 0.002175 | 0.00952 |
| GO:0140453 | protein aggregate center | 1.18% (1/85) | 8.85 | 0.002175 | 0.00952 |
| GO:0045765 | regulation of angiogenesis | 2.35% (2/85) | 4.85 | 0.002222 | 0.009703 |
| GO:0043523 | regulation of neuron apoptotic process | 3.53% (3/85) | 3.54 | 0.002266 | 0.009847 |
| GO:0045121 | membrane raft | 3.53% (3/85) | 3.54 | 0.002266 | 0.009847 |
| GO:0006915 | apoptotic process | 3.53% (3/85) | 3.52 | 0.00232 | 0.010011 |
| GO:0010970 | transport along microtubule | 3.53% (3/85) | 3.52 | 0.00232 | 0.010011 |
| GO:0098857 | membrane microdomain | 3.53% (3/85) | 3.52 | 0.00232 | 0.010011 |
| GO:0043254 | regulation of protein-containing complex assembly | 4.71% (4/85) | 2.86 | 0.002335 | 0.010051 |
| GO:0006626 | protein targeting to mitochondrion | 2.35% (2/85) | 4.8 | 0.002362 | 0.010094 |
| GO:0140678 | molecular function inhibitor activity | 2.35% (2/85) | 4.8 | 0.002362 | 0.010094 |
| GO:1901342 | regulation of vasculature development | 2.35% (2/85) | 4.8 | 0.002362 | 0.010094 |
| GO:0072341 | modified amino acid binding | 3.53% (3/85) | 3.5 | 0.002432 | 0.010367 |
| GO:0009617 | response to bacterium | 15.29% (13/85) | 1.28 | 0.002476 | 0.010532 |
| GO:0061462 | protein localization to lysosome | 2.35% (2/85) | 4.76 | 0.002506 | 0.010583 |
| GO:0005504 | fatty acid binding | 2.35% (2/85) | 4.76 | 0.002506 | 0.010583 |
| GO:0051246 | regulation of protein metabolic process | 14.12% (12/85) | 1.35 | 0.002498 | 0.010601 |
| GO:1903332 | regulation of protein folding | 2.35% (2/85) | 4.72 | 0.002654 | 0.011156 |
| GO:0030150 | protein import into mitochondrial matrix | 2.35% (2/85) | 4.72 | 0.002654 | 0.011156 |
| GO:0098794 | postsynapse | 3.53% (3/85) | 3.45 | 0.002664 | 0.011173 |
| GO:0044260 | cellular macromolecule metabolic process | 18.82% (16/85) | 1.1 | 0.002702 | 0.011307 |
| GO:0050807 | regulation of synapse organization | 3.53% (3/85) | 3.44 | 0.002724 | 0.011373 |
| GO:0010660 | regulation of muscle cell apoptotic process | 2.35% (2/85) | 4.68 | 0.002806 | 0.011687 |
| GO:0048513 | animal organ development | 9.41% (8/85) | 1.73 | 0.002837 | 0.011787 |
| GO:0006325 | chromatin organization | 5.88% (5/85) | 2.37 | 0.002937 | 0.012147 |
| GO:0031399 | regulation of protein modification process | 9.41% (8/85) | 1.72 | 0.002932 | 0.012154 |
| GO:1900101 | regulation of endoplasmic reticulum unfolded protein response | 2.35% (2/85) | 4.64 | 0.002962 | 0.012195 |
| GO:0005703 | polytene chromosome puff | 2.35% (2/85) | 4.64 | 0.002962 | 0.012195 |
| GO:0006807 | nitrogen compound metabolic process | 42.35% (36/85) | 0.6 | 0.002998 | 0.012315 |
| GO:1903573 | negative regulation of response to endoplasmic reticulum stress | 2.35% (2/85) | 4.6 | 0.003122 | 0.012623 |
| GO:0042307 | positive regulation of protein import into nucleus | 2.35% (2/85) | 4.6 | 0.003122 | 0.012623 |
| GO:0005930 | axoneme | 2.35% (2/85) | 4.6 | 0.003122 | 0.012623 |
| GO:0030863 | cortical cytoskeleton | 2.35% (2/85) | 4.6 | 0.003122 | 0.012623 |
| GO:0043014 | alpha-tubulin binding | 2.35% (2/85) | 4.6 | 0.003122 | 0.012623 |
| GO:0005774 | vacuolar membrane | 12.94% (11/85) | 1.39 | 0.003084 | 0.01264 |
| GO:0099111 | microtubule-based transport | 3.53% (3/85) | 3.37 | 0.003103 | 0.012689 |
| GO:0051336 | regulation of hydrolase activity | 5.88% (5/85) | 2.33 | 0.003289 | 0.013266 |
| GO:0016604 | nuclear body | 7.06% (6/85) | 2.02 | 0.003659 | 0.014725 |
| GO:0042742 | defense response to bacterium | 11.76% (10/85) | 1.44 | 0.003696 | 0.014842 |
| GO:0032981 | mitochondrial respiratory chain complex I assembly | 2.35% (2/85) | 4.45 | 0.003803 | 0.015236 |
| GO:0030705 | cytoskeleton-dependent intracellular transport | 3.53% (3/85) | 3.25 | 0.003954 | 0.015809 |
| GO:0005743 | mitochondrial inner membrane | 3.53% (3/85) | 3.24 | 0.004031 | 0.016079 |
| GO:0050776 | regulation of immune response | 10.59% (9/85) | 1.53 | 0.004042 | 0.016087 |
| GO:0009409 | response to cold | 11.76% (10/85) | 1.42 | 0.004081 | 0.016205 |
| GO:0000003 | reproduction | 3.53% (3/85) | 3.23 | 0.004109 | 0.016244 |
| GO:0031982 | vesicle | 14.12% (12/85) | 1.26 | 0.004102 | 0.016255 |
| GO:0098793 | presynapse | 3.53% (3/85) | 3.2 | 0.004347 | 0.016999 |
| GO:0071931 | positive regulation of transcription involved in G1/S transition of mitotic cell cycle | 1.18% (1/85) | 7.85 | 0.004344 | 0.017027 |
| GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity | 1.18% (1/85) | 7.85 | 0.004344 | 0.017027 |
| GO:0018197 | peptidyl-aspartic acid modification | 1.18% (1/85) | 7.85 | 0.004344 | 0.017027 |
| GO:0061684 | chaperone-mediated autophagy | 1.18% (1/85) | 7.85 | 0.004344 | 0.017027 |
| GO:0008137 | NADH dehydrogenase (ubiquinone) activity | 2.35% (2/85) | 4.32 | 0.004546 | 0.017737 |
| GO:0048545 | response to steroid hormone | 3.53% (3/85) | 3.17 | 0.004593 | 0.017885 |
| GO:0034330 | cell junction organization | 3.53% (3/85) | 3.16 | 0.004677 | 0.018172 |
| GO:0051879 | Hsp90 protein binding | 2.35% (2/85) | 4.29 | 0.004741 | 0.01834 |
| GO:0044238 | primary metabolic process | 45.88% (39/85) | 0.53 | 0.004734 | 0.018354 |
| GO:1901998 | toxin transport | 2.35% (2/85) | 4.26 | 0.00494 | 0.018907 |
| GO:0010257 | NADH dehydrogenase complex assembly | 2.35% (2/85) | 4.26 | 0.00494 | 0.018907 |
| GO:0000413 | protein peptidyl-prolyl isomerization | 2.35% (2/85) | 4.26 | 0.00494 | 0.018907 |
| GO:0007601 | visual perception | 2.35% (2/85) | 4.26 | 0.00494 | 0.018907 |
| GO:0043392 | negative regulation of DNA binding | 2.35% (2/85) | 4.26 | 0.00494 | 0.018907 |
| GO:0008092 | cytoskeletal protein binding | 7.06% (6/85) | 1.93 | 0.004955 | 0.018926 |
| GO:0010562 | positive regulation of phosphorus metabolic process | 4.71% (4/85) | 2.53 | 0.005249 | 0.019961 |
| GO:0045937 | positive regulation of phosphate metabolic process | 4.71% (4/85) | 2.53 | 0.005249 | 0.019961 |
| GO:0019866 | organelle inner membrane | 4.71% (4/85) | 2.52 | 0.005307 | 0.020138 |
| GO:0031110 | regulation of microtubule polymerization or depolymerization | 2.35% (2/85) | 4.2 | 0.00535 | 0.020217 |
| GO:0050953 | sensory perception of light stimulus | 2.35% (2/85) | 4.2 | 0.00535 | 0.020217 |
| GO:0032092 | positive regulation of protein binding | 2.35% (2/85) | 4.17 | 0.00556 | 0.020968 |
| GO:0019220 | regulation of phosphate metabolic process | 7.06% (6/85) | 1.89 | 0.005791 | 0.021793 |
| GO:0098588 | bounding membrane of organelle | 16.47% (14/85) | 1.07 | 0.006093 | 0.022881 |
| GO:0032984 | protein-containing complex disassembly | 3.53% (3/85) | 3.02 | 0.006149 | 0.023042 |
| GO:0010646 | regulation of cell communication | 16.47% (14/85) | 1.07 | 0.006162 | 0.023044 |
| GO:0051174 | regulation of phosphorus metabolic process | 7.06% (6/85) | 1.86 | 0.006246 | 0.023308 |
| GO:0032502 | developmental process | 40.0% (34/85) | 0.57 | 0.0063 | 0.023462 |
| GO:2000671 | regulation of motor neuron apoptotic process | 1.18% (1/85) | 7.26 | 0.00651 | 0.023654 |
| GO:2000672 | negative regulation of motor neuron apoptotic process | 1.18% (1/85) | 7.26 | 0.00651 | 0.023654 |
| GO:0046498 | S-adenosylhomocysteine metabolic process | 1.18% (1/85) | 7.26 | 0.00651 | 0.023654 |
| GO:0012502 | induction of programmed cell death | 1.18% (1/85) | 7.26 | 0.00651 | 0.023654 |
| GO:0000737 | DNA catabolic process, endonucleolytic | 1.18% (1/85) | 7.26 | 0.00651 | 0.023654 |
| GO:0045345 | positive regulation of MHC class I biosynthetic process | 1.18% (1/85) | 7.26 | 0.00651 | 0.023654 |
| GO:0051133 | regulation of NK T cell activation | 1.18% (1/85) | 7.26 | 0.00651 | 0.023654 |
| GO:0051135 | positive regulation of NK T cell activation | 1.18% (1/85) | 7.26 | 0.00651 | 0.023654 |
| GO:0046483 | heterocycle metabolic process | 23.53% (20/85) | 0.84 | 0.006413 | 0.023831 |
| GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 2.35% (2/85) | 4.06 | 0.00644 | 0.023834 |
| GO:0009898 | cytoplasmic side of plasma membrane | 2.35% (2/85) | 4.06 | 0.00644 | 0.023834 |
| GO:0044092 | negative regulation of molecular function | 7.06% (6/85) | 1.85 | 0.006483 | 0.023943 |
| GO:0042306 | regulation of protein import into nucleus | 2.35% (2/85) | 4.04 | 0.006669 | 0.024135 |
| GO:0010977 | negative regulation of neuron projection development | 2.35% (2/85) | 4.04 | 0.006669 | 0.024135 |
| GO:0031966 | mitochondrial membrane | 4.71% (4/85) | 2.43 | 0.006688 | 0.024153 |
| GO:0006633 | fatty acid biosynthetic process | 4.71% (4/85) | 2.42 | 0.006755 | 0.024349 |
| GO:0006338 | chromatin remodeling | 4.71% (4/85) | 2.42 | 0.006824 | 0.024547 |
| GO:0072521 | purine-containing compound metabolic process | 5.88% (5/85) | 2.07 | 0.006855 | 0.02461 |
| GO:0019646 | aerobic electron transport chain | 2.35% (2/85) | 4.01 | 0.006902 | 0.024679 |
| GO:0008023 | transcription elongation factor complex | 2.35% (2/85) | 4.01 | 0.006902 | 0.024679 |
| GO:0070201 | regulation of establishment of protein localization | 4.71% (4/85) | 2.41 | 0.006962 | 0.024844 |
| GO:0016607 | nuclear speck | 4.71% (4/85) | 2.4 | 0.007102 | 0.025293 |
| GO:0045292 | mRNA cis splicing, via spliceosome | 2.35% (2/85) | 3.99 | 0.007138 | 0.025373 |
| GO:0005747 | mitochondrial respiratory chain complex I | 2.35% (2/85) | 3.96 | 0.007378 | 0.026071 |
| GO:0030964 | NADH dehydrogenase complex | 2.35% (2/85) | 3.96 | 0.007378 | 0.026071 |
| GO:0045271 | respiratory chain complex I | 2.35% (2/85) | 3.96 | 0.007378 | 0.026071 |
| GO:1901214 | regulation of neuron death | 3.53% (3/85) | 2.92 | 0.007415 | 0.026096 |
| GO:1901654 | response to ketone | 3.53% (3/85) | 2.92 | 0.007415 | 0.026096 |
| GO:0016651 | oxidoreductase activity, acting on NAD(P)H | 3.53% (3/85) | 2.91 | 0.007526 | 0.026438 |
| GO:0030426 | growth cone | 2.35% (2/85) | 3.94 | 0.007622 | 0.026618 |
| GO:1902288 | regulation of defense response to oomycetes | 2.35% (2/85) | 3.94 | 0.007622 | 0.026618 |
| GO:0051239 | regulation of multicellular organismal process | 16.47% (14/85) | 1.04 | 0.0076 | 0.026643 |
| GO:0009892 | negative regulation of metabolic process | 16.47% (14/85) | 1.03 | 0.007807 | 0.027212 |
| GO:0030665 | clathrin-coated vesicle membrane | 2.35% (2/85) | 3.91 | 0.007869 | 0.027375 |
| GO:0006605 | protein targeting | 4.71% (4/85) | 2.35 | 0.00798 | 0.027708 |
| GO:0005776 | autophagosome | 2.35% (2/85) | 3.89 | 0.00812 | 0.027977 |
| GO:0016226 | iron-sulfur cluster assembly | 2.35% (2/85) | 3.89 | 0.00812 | 0.027977 |
| GO:0031163 | metallo-sulfur cluster assembly | 2.35% (2/85) | 3.89 | 0.00812 | 0.027977 |
| GO:0000791 | euchromatin | 2.35% (2/85) | 3.89 | 0.00812 | 0.027977 |
| GO:0051050 | positive regulation of transport | 5.88% (5/85) | 2.0 | 0.008347 | 0.028704 |
| GO:0032268 | regulation of cellular protein metabolic process | 2.35% (2/85) | 3.87 | 0.008375 | 0.028743 |
| GO:0008380 | RNA splicing | 4.71% (4/85) | 2.33 | 0.008525 | 0.029202 |
| GO:0051998 | protein carboxyl O-methyltransferase activity | 1.18% (1/85) | 6.85 | 0.00867 | 0.029254 |
| GO:0004807 | triose-phosphate isomerase activity | 1.18% (1/85) | 6.85 | 0.00867 | 0.029254 |
| GO:0008929 | methylglyoxal synthase activity | 1.18% (1/85) | 6.85 | 0.00867 | 0.029254 |
| GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process | 1.18% (1/85) | 6.85 | 0.00867 | 0.029254 |
| GO:0030520 | intracellular estrogen receptor signaling pathway | 1.18% (1/85) | 6.85 | 0.00867 | 0.029254 |
| GO:0044748 | 3'-5'-exoribonuclease activity involved in mature miRNA 3'-end processing | 1.18% (1/85) | 6.85 | 0.00867 | 0.029254 |
| GO:0045343 | regulation of MHC class I biosynthetic process | 1.18% (1/85) | 6.85 | 0.00867 | 0.029254 |
| GO:0051252 | regulation of RNA metabolic process | 18.82% (16/85) | 0.93 | 0.008728 | 0.029392 |
| GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor | 2.35% (2/85) | 3.85 | 0.008633 | 0.029516 |
| GO:1900182 | positive regulation of protein localization to nucleus | 2.35% (2/85) | 3.82 | 0.008894 | 0.029786 |
| GO:0003955 | NAD(P)H dehydrogenase (quinone) activity | 2.35% (2/85) | 3.82 | 0.008894 | 0.029786 |
| GO:0050136 | NADH dehydrogenase (quinone) activity | 2.35% (2/85) | 3.82 | 0.008894 | 0.029786 |
| GO:0031969 | chloroplast membrane | 4.71% (4/85) | 2.3 | 0.009092 | 0.030336 |
| GO:0031401 | positive regulation of protein modification process | 5.88% (5/85) | 1.97 | 0.009078 | 0.030344 |
| GO:0046824 | positive regulation of nucleocytoplasmic transport | 2.35% (2/85) | 3.8 | 0.009159 | 0.030503 |
| GO:0043524 | negative regulation of neuron apoptotic process | 2.35% (2/85) | 3.78 | 0.009428 | 0.031167 |
| GO:0003954 | NADH dehydrogenase activity | 2.35% (2/85) | 3.78 | 0.009428 | 0.031167 |
| GO:0031491 | nucleosome binding | 2.35% (2/85) | 3.78 | 0.009428 | 0.031167 |
| GO:1901360 | organic cyclic compound metabolic process | 27.06% (23/85) | 0.71 | 0.009486 | 0.0313 |
| GO:0002218 | activation of innate immune response | 4.71% (4/85) | 2.28 | 0.009428 | 0.031339 |
| GO:0006259 | DNA metabolic process | 8.24% (7/85) | 1.56 | 0.009705 | 0.031907 |
| GO:0016859 | cis-trans isomerase activity | 2.35% (2/85) | 3.76 | 0.0097 | 0.031948 |
| GO:0098852 | lytic vacuole membrane | 3.53% (3/85) | 2.77 | 0.009844 | 0.032305 |
| GO:0098978 | glutamatergic synapse | 3.53% (3/85) | 2.76 | 0.009977 | 0.032679 |
| GO:0042170 | plastid membrane | 7.06% (6/85) | 1.72 | 0.010077 | 0.032888 |
| GO:0042594 | response to starvation | 7.06% (6/85) | 1.72 | 0.010077 | 0.032888 |
| GO:0070370 | cellular heat acclimation | 2.35% (2/85) | 3.72 | 0.010255 | 0.033407 |
| GO:0036002 | pre-mRNA binding | 2.35% (2/85) | 3.7 | 0.010537 | 0.034265 |
| GO:0001554 | luteolysis | 1.18% (1/85) | 6.52 | 0.010826 | 0.034456 |
| GO:1904313 | response to methamphetamine hydrochloride | 1.18% (1/85) | 6.52 | 0.010826 | 0.034456 |
| GO:0030576 | Cajal body organization | 1.18% (1/85) | 6.52 | 0.010826 | 0.034456 |
| GO:0033530 | raffinose metabolic process | 1.18% (1/85) | 6.52 | 0.010826 | 0.034456 |
| GO:0034484 | raffinose catabolic process | 1.18% (1/85) | 6.52 | 0.010826 | 0.034456 |
| GO:0047268 | galactinol-raffinose galactosyltransferase activity | 1.18% (1/85) | 6.52 | 0.010826 | 0.034456 |
| GO:0009353 | mitochondrial oxoglutarate dehydrogenase complex | 1.18% (1/85) | 6.52 | 0.010826 | 0.034456 |
| GO:0042359 | vitamin D metabolic process | 1.18% (1/85) | 6.52 | 0.010826 | 0.034456 |
| GO:0001405 | PAM complex, Tim23 associated import motor | 1.18% (1/85) | 6.52 | 0.010826 | 0.034456 |
| GO:0032558 | adenyl deoxyribonucleotide binding | 1.18% (1/85) | 6.52 | 0.010826 | 0.034456 |
| GO:0032564 | dATP binding | 1.18% (1/85) | 6.52 | 0.010826 | 0.034456 |
| GO:0043412 | macromolecule modification | 21.18% (18/85) | 0.82 | 0.011 | 0.034948 |
| GO:0008289 | lipid binding | 5.88% (5/85) | 1.91 | 0.01081 | 0.035089 |
| GO:0033293 | monocarboxylic acid binding | 2.35% (2/85) | 3.66 | 0.011112 | 0.035242 |
| GO:0010243 | response to organonitrogen compound | 10.59% (9/85) | 1.29 | 0.011201 | 0.03546 |
| GO:0000978 | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 4.71% (4/85) | 2.21 | 0.011226 | 0.035476 |
| GO:0008378 | galactosyltransferase activity | 2.35% (2/85) | 3.64 | 0.011405 | 0.035979 |
| GO:1901564 | organonitrogen compound metabolic process | 32.94% (28/85) | 0.6 | 0.011462 | 0.036096 |
| GO:0006357 | regulation of transcription by RNA polymerase II | 9.41% (8/85) | 1.38 | 0.011609 | 0.036494 |
| GO:0030662 | coated vesicle membrane | 2.35% (2/85) | 3.6 | 0.012001 | 0.037594 |
| GO:0031345 | negative regulation of cell projection organization | 2.35% (2/85) | 3.6 | 0.012001 | 0.037594 |
| GO:0031324 | negative regulation of cellular metabolic process | 12.94% (11/85) | 1.12 | 0.012032 | 0.037627 |
| GO:0051604 | protein maturation | 3.53% (3/85) | 2.66 | 0.012085 | 0.037726 |
| GO:0032968 | positive regulation of transcription elongation by RNA polymerase II | 2.35% (2/85) | 3.58 | 0.012303 | 0.038341 |
| GO:0031410 | cytoplasmic vesicle | 11.76% (10/85) | 1.17 | 0.012979 | 0.039756 |
| GO:0021589 | cerebellum structural organization | 1.18% (1/85) | 6.26 | 0.012978 | 0.03982 |
| GO:2001295 | malonyl-CoA biosynthetic process | 1.18% (1/85) | 6.26 | 0.012978 | 0.03982 |
| GO:0061564 | axon development | 1.18% (1/85) | 6.26 | 0.012978 | 0.03982 |
| GO:0140467 | integrated stress response signaling | 1.18% (1/85) | 6.26 | 0.012978 | 0.03982 |
| GO:0047274 | galactinol-sucrose galactosyltransferase activity | 1.18% (1/85) | 6.26 | 0.012978 | 0.03982 |
| GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity | 1.18% (1/85) | 6.26 | 0.012978 | 0.03982 |
| GO:0032554 | purine deoxyribonucleotide binding | 1.18% (1/85) | 6.26 | 0.012978 | 0.03982 |
| GO:0061084 | negative regulation of protein refolding | 1.18% (1/85) | 6.26 | 0.012978 | 0.03982 |
| GO:0015453 | oxidoreduction-driven active transmembrane transporter activity | 2.35% (2/85) | 3.54 | 0.012919 | 0.04019 |
| GO:0070417 | cellular response to cold | 3.53% (3/85) | 2.62 | 0.01315 | 0.040211 |
| GO:0000381 | regulation of alternative mRNA splicing, via spliceosome | 2.35% (2/85) | 3.52 | 0.013232 | 0.040393 |
| GO:0051172 | negative regulation of nitrogen compound metabolic process | 12.94% (11/85) | 1.1 | 0.013412 | 0.040874 |
| GO:0009150 | purine ribonucleotide metabolic process | 4.71% (4/85) | 2.13 | 0.013551 | 0.041156 |
| GO:0010623 | programmed cell death involved in cell development | 2.35% (2/85) | 3.51 | 0.013548 | 0.041217 |
| GO:0006909 | phagocytosis | 2.35% (2/85) | 3.47 | 0.01419 | 0.042951 |
| GO:0047485 | protein N-terminus binding | 2.35% (2/85) | 3.47 | 0.01419 | 0.042951 |
| GO:0009506 | plasmodesma | 15.29% (13/85) | 0.97 | 0.014414 | 0.043557 |
| GO:0044237 | cellular metabolic process | 45.88% (39/85) | 0.44 | 0.014461 | 0.043626 |
| GO:0009306 | protein secretion | 2.35% (2/85) | 3.42 | 0.015176 | 0.044659 |
| GO:0035592 | establishment of protein localization to extracellular region | 2.35% (2/85) | 3.42 | 0.015176 | 0.044659 |
| GO:0071692 | protein localization to extracellular region | 2.35% (2/85) | 3.42 | 0.015176 | 0.044659 |
| GO:0006606 | protein import into nucleus | 2.35% (2/85) | 3.42 | 0.015176 | 0.044659 |
| GO:1905897 | regulation of response to endoplasmic reticulum stress | 2.35% (2/85) | 3.44 | 0.014844 | 0.044707 |
| GO:0051402 | neuron apoptotic process | 1.18% (1/85) | 6.04 | 0.015124 | 0.044799 |
| GO:0035694 | mitochondrial protein catabolic process | 1.18% (1/85) | 6.04 | 0.015124 | 0.044799 |
| GO:0052692 | raffinose alpha-galactosidase activity | 1.18% (1/85) | 6.04 | 0.015124 | 0.044799 |
| GO:0043335 | protein unfolding | 1.18% (1/85) | 6.04 | 0.015124 | 0.044799 |
| GO:0019237 | centromeric DNA binding | 1.18% (1/85) | 6.04 | 0.015124 | 0.044799 |
| GO:0021772 | olfactory bulb development | 1.18% (1/85) | 6.04 | 0.015124 | 0.044799 |
| GO:0032767 | copper-dependent protein binding | 1.18% (1/85) | 6.04 | 0.015124 | 0.044799 |
| GO:0000738 | DNA catabolic process, exonucleolytic | 1.18% (1/85) | 6.04 | 0.015124 | 0.044799 |
| GO:0010587 | miRNA catabolic process | 1.18% (1/85) | 6.04 | 0.015124 | 0.044799 |
| GO:0018885 | carbon tetrachloride metabolic process | 1.18% (1/85) | 6.04 | 0.015124 | 0.044799 |
| GO:0010975 | regulation of neuron projection development | 3.53% (3/85) | 2.54 | 0.015265 | 0.044847 |
| GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 3.53% (3/85) | 2.53 | 0.015436 | 0.045273 |
| GO:0097708 | intracellular vesicle | 11.76% (10/85) | 1.13 | 0.015527 | 0.045466 |
| GO:0043025 | neuronal cell body | 3.53% (3/85) | 2.52 | 0.015607 | 0.045626 |
| GO:0006163 | purine nucleotide metabolic process | 4.71% (4/85) | 2.06 | 0.015687 | 0.045786 |
| GO:0016592 | mediator complex | 2.35% (2/85) | 3.39 | 0.01585 | 0.046188 |
| GO:0015934 | large ribosomal subunit | 3.53% (3/85) | 2.51 | 0.015953 | 0.046411 |
| GO:0008152 | metabolic process | 51.76% (44/85) | 0.38 | 0.016202 | 0.046982 |
| GO:0018208 | peptidyl-proline modification | 2.35% (2/85) | 3.37 | 0.016192 | 0.047031 |
| GO:0065008 | regulation of biological quality | 20.0% (17/85) | 0.79 | 0.016328 | 0.047272 |
| GO:0000375 | RNA splicing, via transesterification reactions | 3.53% (3/85) | 2.49 | 0.01648 | 0.047635 |
| GO:0034243 | regulation of transcription elongation by RNA polymerase II | 2.35% (2/85) | 3.35 | 0.016537 | 0.047724 |
| GO:0005788 | endoplasmic reticulum lumen | 2.35% (2/85) | 3.34 | 0.016885 | 0.048494 |
| GO:0050897 | cobalt ion binding | 2.35% (2/85) | 3.34 | 0.016885 | 0.048494 |
| GO:0032786 | positive regulation of DNA-templated transcription, elongation | 2.35% (2/85) | 3.34 | 0.016885 | 0.048494 |
| GO:0005576 | extracellular region | 10.59% (9/85) | 1.19 | 0.017019 | 0.048801 |
| GO:0070997 | neuron death | 1.18% (1/85) | 5.85 | 0.017266 | 0.04904 |
| GO:0009317 | acetyl-CoA carboxylase complex | 1.18% (1/85) | 5.85 | 0.017266 | 0.04904 |
| GO:0051455 | monopolar spindle attachment to meiosis I kinetochore | 1.18% (1/85) | 5.85 | 0.017266 | 0.04904 |
| GO:0031906 | late endosome lumen | 1.18% (1/85) | 5.85 | 0.017266 | 0.04904 |
| GO:1904592 | positive regulation of protein refolding | 1.18% (1/85) | 5.85 | 0.017266 | 0.04904 |
| GO:1903333 | negative regulation of protein folding | 1.18% (1/85) | 5.85 | 0.017266 | 0.04904 |
| GO:0005911 | cell-cell junction | 15.29% (13/85) | 0.93 | 0.017446 | 0.049472 |
| GO:0090316 | positive regulation of intracellular protein transport | 2.35% (2/85) | 3.31 | 0.01759 | 0.049803 |
| GO:0009259 | ribonucleotide metabolic process | 4.71% (4/85) | 2.01 | 0.017642 | 0.04987 |